Showing 20 of 10259 recruiting trials
A Long-Term Study of Navenibart in Participants With Hereditary Angioedema
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis
Study of COYA 302 for the Treatment of ALS
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers
RecruitingNCT07352332 ↗
Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTE
🏥 The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Sep 2025View details ↗
A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
👨⚕️ Teva Medical Expert, MD, Teva Branded Pharmaceutical Products R&D LLC📍 5 sites📅 Started Sep 2025View details ↗
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
RecruitingNCT07234656 ↗
Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer
RecruitingNCT06865482 ↗
Clinical Course Of Disease In Participants With FA-CM
Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis
RecruitingNCT07242963 ↗
Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1
Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy
A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
Safety and Efficacy of FETO in CDH Phase III
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →